Sinus Dilation Devices Market Size, Share & Trends Report

Sinus Dilation Devices Market Size, Share & Trends Analysis Report By Product, By Procedure (Standalone, Hybrid), By Application (Adult, Pediatric), By End Use (ENT Clinics, Hospitals), And Segment Forecasts, 2018 - 2025

  • Published Date: Nov, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-634-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 119

Industry Insights

The global sinus dilation devices market size was estimated at USD 1.79 billion in 2017. It is likely to witness a CAGR of 8.9% during the forecast period. Growing healthcare expenditure in developed, as well as developing, economies is anticipated to be one of the major factors contributing to the market expansion. Arise in awareness levels regarding Minimally Invasive Surgery (MIS), especially in emerging regions like Asia Pacific, is also expected to boost the market development over the next few years.

Growing adoption of MIS in developed, as well as developing, countries owing to the advantages associated with it, such as reduced blood loss and less recovery time and hospital stays is likely to propel the growth of this market. Minimally invasive surgeries, such as Functional Endoscopic Sinus Surgery (FESS), are widely used procedures owing to favorable reimbursement criteria, higher success rate than other procedures.

North America sinus dilation devices market

Furthermore, various technological advancements and new product launches are the key growth-driving factors for this industry. Thus, rising R&D activities by key companies like Acclarent, Inc. and Smith & Nephew Plc. will have a major impact on the market growth.For instance, in April 2018, Intersect ENT Inc. launched Sinuva for the treatment of polyp disease in adults who have undergone sinus surgery.

Another instance includes the launch of XprESS LoProfile Multi-Sinus Dilation System. Launched in Europe in 2015, these surgical tools are equipped with multi-functional system, which combines balloon dilation with irrigation, suction, and image guidance.

Product Insights

The product segment is divided into balloon sinus dilation devices, sinuscopes, rhinoscopes, sinus stents/implants, FESS instrument set, and others. Balloon sinus dilation devices held the largest share of the global market in 2017. They are used for balloon sinuplasty, a non-surgical procedure for the treatment of chronic sinusitis.

This growth was attributed to the increased prevalence of chronic sinusitis and adoption of balloon sinuplasty procedures. Moreover, preference for these over traditional surgeries also contributed to the segment growth. The segment is projected to expand further over the next few years on account of advancements in surgical procedures.

Procedure Insights

On the basis of procedure, the global market is bifurcated into stand-alone and hybrid procedures. Standalone procedures held the major share of the market in 2017. The most widely performed stand-alone procedures include BSOD and FESS. These procedures are used for treating chronic sinusitis. According to the International Forum of Allergy & Rhinology (2017), in U.S., the use of balloon sinuplasty stand-alone procedure has increased from 5% in 2011 to 22.5% in 2014. The report further states that in 2014, around 67.9% stand-alone FESS procedures were performed.

Application Insights

On the basis of application, the market has been divided into adult and pediatric patients. The adult segment held the maximum share of this market in 2017 as a result of a rise in the prevalence of sinusitis among adults. In addition, growing healthcare expenditure levels coupled with rising awareness about the treatments of chronic rhinosinusitis will further boost the growth of this segment. According to a survey conducted by the Centers for Disease Controls and Prevention, viral sinusitis was more common among adults than it is in children, i.e. 9 out of 10 cases in adults were observed in U.S.

End-use Insights

On the basis of end-uses, the market is categorized into hospitals, ENT clinics/in office, and Ambulatory Surgical Centers (ASCs). The ENT clinics/in office segment is anticipated to be the fastest-growing segment over the coming years. On the otherhand, the hospitals segment will account for the maxmum market share over the forecast period.

Global sinus dilation devices market

This growth can be attributed to the rise in the number of surgical procedures performed in these settings and availability of favorable reimbursement policies. Rapidly improving infrastructure facilities and healthcare expenditure in developing countries, such as India, Mexico, Brazil, China, will further fuel the growth of the hospital segment. For instance, according to The World Bank data, in 2015, health expenditure as a share of total GDP was 8.4% for Brazil.

Regional Insights

North America held the major share of the global sinus dilation devices market in 2017. It is estimated to expand further in the years to come. Efforts by key companies to expand product portfolio and ensure high-quality standards are expected to boost the demand for sinus dilation device across the region. For instance, in July 2016, Acclarent, Inc. introduced multi-sinus dilation system RELIEVA SCOUT, in the U.S. market.

However, Asia Pacific is anticipated to register the fastest CAGR during the forecast period. This is mainly due to the presence of large patient pool. According to the study conducted by Indian Council of Medical Research (2017), approximately 15% population of India was found to be affected by chronic sinusitis in 2016.In addition, rising adoption of technologically advanced products and minimally invasive procedures due to penetration of healthcare insurance system will drive the segment growth.

Sinus Dilation Devices Market Share Insights

Medtronic PLC; Smith & Nephew PLC; Acclarent, Inc.; Intersect ENT, Inc.; Entellus Medical, Inc.; Olympus Corporation; and SinuSys Corporation are some of the key companies operating in the global market. Most of these companies focus on R&D to deliver technically advanced products.

For instance, in April 2018, Intersect ENT, Inc., a U.S.-based company, launched SINUVA sinus implant for the treatment of nasal polyp disease in adults. M&A is another popular market strategy among these pioneers. For instance, in April 2017, Olympus Corporation entered into a definitive contract to acquire Image Stream Medical, Inc. to improve medical solution assistance to healthcare facilities.

Report Scope

Attribute

Details

Base year for estimation

2017

Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country scope

U.S., Canada, Germany, U.K., Japan, China, India, Brazil, Mexico, and South Africa,

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global sinus dilation devices market report on the basis of product, procedure, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Balloon Sinus Dilation Devices

    • Endoscopes

    • Sinuscopes

    • Rhinoscopes

    • Sinus Stents/Implants

    • Functional Endoscopic Sinus Surgery (FESS) Instruments Set

    • Others

  • Procedure Outlook (Revenue, USD Million, 2014 - 2025)

    • Stand-alone

    • Hybrid

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Adult

    • Pediatric

  • End-use Outlook (Revenue, USD Million, 2014 - 2025)

    • Hospitals

    • ENT Clinics

    • Ambulatory Surgery Centres

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified